metformin has been researched along with thromboplastin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, M; Harada, N; Komura, H; Mizuochi, Y; Okajima, K; Uchiba, M | 1 |
| Ciaraldi, TP; Samad, F; Wang, J | 1 |
| Ai, Q; Ao, JE; Duan, R; Ge, P; Gong, X; Lin, L; Zhang, L | 1 |
| Candido, AL; Carvalho, LML; Ferreira, CN; Gomes, KB; Nunes, FFC; Reis, FM; Sales, MF; Silva, IFO; Sóter, MO | 1 |
| Broncel, M; Huttunen, KM; Markowicz-Piasecka, M; Sikora, J | 1 |
| Dörner, A; Friebel, J; Grabitz, S; Jakobs, K; Landmesser, U; Rauch, U; Stratmann, B; Tabaraie, T; Taghipour, L; Tschoepe, D; Witkowski, M | 1 |
| Dai, X; De, Z; Gao, L; Hu, J; Li, G; Li, L; Xu, F; Zhang, Y | 1 |
1 trial(s) available for metformin and thromboplastin
| Article | Year |
|---|---|
Tissue factor expression in obese type 2 diabetic subjects and its regulation by antidiabetic agents.
Topics: Adult; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Gene Expression Regulation; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Obesity; Rosiglitazone; Thiazolidinediones; Thromboplastin | 2015 |
6 other study(ies) available for metformin and thromboplastin
| Article | Year |
|---|---|
Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro.
Topics: Apoptosis; Blotting, Western; Cell Survival; Cells, Cultured; Early Growth Response Protein 1; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Humans; Hypoglycemic Agents; Lipopolysaccharides; Lipoproteins, LDL; Metformin; Monocytes; Phosphorylation; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; Thromboplastin; Tumor Necrosis Factor-alpha | 2010 |
Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D‑galactosamine‑induced fulminant hepatitis.
Topics: Animals; Anti-Inflammatory Agents; Blood Coagulation; Disease Models, Animal; Erythropoietin; Galactosamine; Hepatitis; Hypoglycemic Agents; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Interleukin-6; Lactic Acid; Lipopolysaccharides; Liver; Matrix Metalloproteinase 3; Metformin; Mice; NF-kappa B; Plasminogen Activator Inhibitor 1; RNA, Messenger; Thromboplastin; Up-Regulation; Vascular Endothelial Growth Factor A | 2015 |
Metformin reduces total microparticles and microparticles-expressing tissue factor in women with polycystic ovary syndrome.
Topics: Adult; Cell-Derived Microparticles; Female; Hemostatics; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Thromboplastin | 2017 |
Sulfenamide and Sulfonamide Derivatives of Metformin - A New Option to Improve Endothelial Function and Plasma Haemostasis.
Topics: Diabetes Mellitus, Type 2; Human Umbilical Vein Endothelial Cells; Humans; Metformin; Myocytes, Smooth Muscle; Sulfamerazine; Sulfonamides; Thromboplastin; von Willebrand Factor | 2019 |
Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes.
Topics: C-Reactive Protein; Diabetes Mellitus, Type 2; Drug Resistance; Female; Fibrinolytic Agents; Glycated Hemoglobin; Heart Disease Risk Factors; Humans; Hypoglycemic Agents; Leukocyte Count; Male; Metformin; MicroRNAs; Middle Aged; Peroxidase; THP-1 Cells; Thromboplastin; Vascular Cell Adhesion Molecule-1 | 2021 |
Metformin Inhibits Multiple Myeloma Serum-induced Endothelial Cell Thrombosis by Down-Regulating miR-532.
Topics: Cells, Cultured; Endothelial Protein C Receptor; Fibrinolytic Agents; Human Umbilical Vein Endothelial Cells; Humans; Metformin; MicroRNAs; Multiple Myeloma; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Protein C; Quality of Life; Thrombin; Thromboplastin; Thrombosis; Treatment Outcome | 2022 |